Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies.

Bibliographic Details
Title: Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies.
Authors: Wang, Jie1 (AUTHOR) helenajiewang@163.com, Wang, Meifeng1 (AUTHOR), Zeng, Xueni1 (AUTHOR), Li, Yanhan1 (AUTHOR), Lei, Lingzhi1 (AUTHOR), Chen, Changan1 (AUTHOR), Lin, Xi1 (AUTHOR), Fang, Peiyuan1 (AUTHOR), Guo, Yuxuan2 (AUTHOR), Jiang, Xianjie3 (AUTHOR), Wang, Yian2 (AUTHOR), Chen, Lihong1,4 (AUTHOR) drlhchen@sina.com, Long, Jun5 (AUTHOR) longjun1988@126.com
Source: Cell Communication & Signaling. 2/15/2025, Vol. 23 Issue 1, p1-26. 26p.
Subject Terms: *LIPID metabolism, *LIPID synthesis, *CELL physiology, *LIFE sciences, *CYTOLOGY, *HOMEOSTASIS
Abstract: Membrane contact sites (MCS) are specialized regions where organelles are closely interconnected through membrane structures, facilitating the transfer and exchange of ions, lipids, and other molecules. This proximity enables a synergistic regulation of cellular homeostasis and functions. The formation and maintenance of these contact sites are governed by specific proteins that bring organelle membranes into close apposition, thereby enabling functional crosstalk between cellular compartments. In eukaryotic cells, lipids are primarily synthesized and metabolized within distinct organelles and must be transported through MCS to ensure proper cellular function. Consequently, MCS act as pivotal platforms for lipid synthesis and trafficking, particularly in cancer cells and immune cells within the tumor microenvironment, where dynamic alterations are critical for maintaining lipid homeostasis. This article provides a comprehensive analysis of how these cells exploit membrane contact sites to modulate lipid synthesis, metabolism, and transport, with a specific focus on how MCS-mediated lipid dynamics influence tumor progression. We also examine the differences in MCS and associated molecules across various cancer types, exploring novel therapeutic strategies targeting MCS-related lipid metabolism for the development of anticancer drugs, while also addressing the challenges involved. [ABSTRACT FROM AUTHOR]
Copyright of Cell Communication & Signaling is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:1478811X
DOI:10.1186/s12964-025-02089-z
Published in:Cell Communication & Signaling
Language:English